Subjects were 981 cases of hepatocellular carcinomas (HCC). We divided these subjects into 12 categories according to TNM Stage (I, II, III, IV) and Liver damage (A, B, C). Then we compared the therapy rates of use and those survival rates in each category.
The treatment outcome of ablation in Stage I was the same as hepatectomy. On the other hand, in the case of more than Stage II, treatment outcome of hepatectomy was better than those of the other therapies. As for these results, it was thought that it was important in future when we reviewed the algorithm of HCC treatment.
